CCL4 and neoplasm: In a melanoma mouse model, the decrease of CCL4 secretion by tumor cells—following the activation of the β-catenin/Wnt pathway—inhibits cDC1 recruitment into the tumor site and leads to a decrease of the subsequent T-cell infiltration [68].